Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-08-19
2011-11-01
Chong, Yong (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S248000, C514S252100, C514S252120, C514S252130
Reexamination Certificate
active
08048884
ABSTRACT:
The present invention provides selective 5-HT7receptor antagonist compounds of Formula I and their use in the treatment of migraine:where A is —C(H)═ or —N═; m is 0, 1 or 2; R1is optionally substituted phenyl, optionally substituted pyrazol-4-yl; optionally substituted imidazolyl, optionally substituted pyridyl, or thienyl; R2is hydrogen or methyl; and R3and R4are as defined herein.
REFERENCES:
patent: 1254905 (2002-11-01), None
patent: WO 2004/069794 (2004-08-01), None
patent: WO2004/067703 (2007-08-01), None
Leopoldo, “Serotonin(7)receptors(5-HT(7)Rs) and their Ligands”,Curr. Med. Chem., vol. 11, pp. 629-661, (2004).
Cohen Michael Philip
Filla Sandra Ann
Hellman Sarah Lynne
Hollinshead Sean Patrick
Tidwell Michael Wade
Chong Yong
Eli Lilly and Company
Tucker R. Craig
LandOfFree
Substituted piperazinyl pyrazines and pyridines as 5-HT 7... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted piperazinyl pyrazines and pyridines as 5-HT 7..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted piperazinyl pyrazines and pyridines as 5-HT 7... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4282371